CINECA IRIS Institutional Research Information System

Sfoglia per Autore  

Opzioni
Mostrati risultati da 61 a 80 di 232
Titolo Data di pubblicazione Autore(i) File
Stage-specific functions of leukemia/lymphoma-related factor (LRF) in the transcriptional control of osteoclast development. 2012 Tsuji-Takechi K; Negishi-Koga T; Sumiya E; Kukita A; Kato S; Maeda T; Pandolfi PP; Moriyama K; Takayanagi H.
Pro-senescence therapy for cancer treatment. 2011 Nardella C; Clohessy JG; Alimonti A; Pandolfi PP
A continuum model for tumour suppression 2011 Berger AH; Knudson AG; Pandolfi PP
Functional Connection between Rad51 and PML in Homology-Directed Repair 2011 Boichuk S; Hu L; Makielski K; Pandolfi PP; Gjoerup OV
PTEN level in tumor suppression: how much is too little? 2011 Carracedo A; Alimonti A; Pandolfi PP
Treatment with 5-azacytidine accelerates acute promyelocytic leukemia leukemogenesis in a transgenic mouse model. 2011 Scaglioni PP; Cai LF; Majid SM; Yung TM; Socci ND; Kogan SC; Kopelovich L; Pandolfi PP
Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesis. 2011 Nardella C; Lunardi A; Fedele G; Clohessy JG; Alimonti A; Kozma SC; Thomas G; Loda M; Pandolfi PP
The role of PML in the control of apoptotic cell fate: a new key player at ER-mitochondria sites. 2011 Pinton P; Giorgi C; Pandolfi PP
A Role for PML in Innate Immunity. 2011 Lunardi A; Gaboli M; Giorgio M; Rivi R; Bygrave A; Antoniou M; Drabek D; Dzierzak E; Fagioli M; Salmena L; Botto M; Cordon-Cardo C; Luzzatto L; Pelicci PG; Grosveld F; Pandolfi PP
The nuclear bodies inside out: PML conquers the cytoplasm. 2011 Carracedo A; Ito K; Pandolfi PP
Ubiquitination of K-Ras enhances activation and facilitates binding to select downstream effectors. 2011 Sasaki AT; Carracedo A; Locasale JW; Anastasiou D; Takeuchi K; Kahoud ER; Haviv S; Asara JM; Pandolfi PP; Cantley LC
Pml represses tumour progression through inhibition of mTOR. 2011 Bernardi R; Papa A; Egia A; Coltella N; Teruya-Feldstein J; Signoretti S; Pandolfi PP
Mitochondria associated membranes (MAMs) as critical hubs for apoptosis 2011 Giorgi C; Wieckowski MR; Pandolfi PP; Pinton P
Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma. 2011 Jham BC; Ma T; Hu J; Chaisuparat R; Friedman ER; Pandolfi PP; Schneider A; Sodhi A; Montaner S
Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. 2011 Song MS; Carracedo A; Salmena L; Song SJ; Egia A; Malumbres M; Pandolfi PP
Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs 2011 Tay Y; Kats L; Salmena L; Weiss D; Tan SM; Ala U; Karreth F; Poliseno L; Provero P; Di Cunto F; Lieberman J; Rigoutsos I; Pandolfi PP
In Vivo Identification of Tumor- Suppressive PTEN ceRNAs in anOncogenic BRAF-Induced Mouse Model of Melanoma 2011 Karreth FA; Tay Y; Perna D; Ala U; Tan SM; Rust AG; Denicola G; Webster KA; Weiss D; Perez-Mancera PA; Krauthammer M; Halaban R; Provero P; Adams DJ; Tuveson DA; Pandolfi PP
Determining the contribution of NPM1 heterozygosity to NPM-ALK-induced lymphomagenesis. 2011 Mduff FK; Hook CE; Tooze RM; Huntly BJ; Pandolfi PP; Turner SD
Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. 2011 Darido C; Georgy SR; Wilanowski T; Dworkin S; Auden A; Zhao Q; Rank G; Srivastava S; Finlay MJ; Papenfuss AT; Pandolfi PP; Pearson RB; Jane SM.
The APL Paradigm and the "Co-Clinical Trial" Project 2011 Nardella C; Lunardi A; Patnaik A; Cantley LC; Pandolfi PP
Mostrati risultati da 61 a 80 di 232
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile